Why It Matters
Wisconsin correctional facilities have significantly expanded medication-based treatment for opioid use disorder among incarcerated residents, addressing a population at elevated risk for overdose deaths upon release. The shift reflects growing recognition that treating addiction behind bars can reduce fatalities and support recovery after incarceration.
What Happened
A report released Wednesday by the Wisconsin Policy Forum documented a substantial increase in the number of jail and prison residents receiving medications for opioid use disorder between 2021 and 2024. The research was presented at a press conference hosted by the Vital Strategies Overdose Prevention Program, a global public health organization working on overdose prevention and harm reduction strategies.
The medications help incarcerated individuals manage opioid withdrawal symptoms and recover from active addiction. According to the report, newly released prisoners face heightened overdose risk, making treatment during incarceration a critical intervention point.
By the Numbers
Of Wisconsin’s 71 county jails, 58 completed a full 42-question survey and seven provided partial responses, yielding a 97% participation rate. Opioid overdose deaths in Wisconsin peaked in 2024 and have since declined, though overdose fatalities statewide still run slightly higher than vehicle deaths. The report identified three primary factors driving increased medication access in correctional settings.
Zoom Out
The report cited the state’s high opioid death toll, availability of settlement funds from pharmaceutical company lawsuits, and federal pressure as key drivers. The U.S. Department of Justice has pushed facilities to offer opioid use disorder medications under the Americans with Disabilities Act. Professional health agencies have also promoted these treatments as evidence-based standard care.
A fourth factor discussed at the press conference was the rising number of facilities offering the medications, which has helped normalize their use across the correctional system. Jason Stein, president of the Wisconsin Policy Forum, noted that despite the recent decline in opioid deaths, overdoses remain a significant public policy challenge in the state.
What’s Next
The report’s findings are expected to inform ongoing discussions about addiction treatment access in correctional settings. Settlement funds from opioid litigation continue to flow into the state, providing resources for expanded treatment programs. Advocates are likely to use the data to push for broader adoption of medication-assisted treatment across remaining facilities that have not yet implemented such programs.